Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Kritika Sarmah

3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio

The pharmaceutical industry is well-positioned for growth, given its robust demand, increasing healthcare spending and rising global elderly population. So, investors could consider adding quality pharma stocks Dr. Reddy’s Laboratories Limited (RDY), Novo Nordisk A/S (NVO), and AbbVie Inc. (ABBV) to one’s portfolio this month.

The pharmaceutical market is experiencing robust growth driven by innovative drugs and increasing healthcare demand, especially in emerging nations. This year, the global pharmaceutical market is poised to achieve revenues of $1.12 trillion. Looking to the future, the global pharmaceutical market is expected to reach $1.48 trillion by 2028, exhibiting a CAGR of 5.8%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.